Supply chains create global benefits from improved vaccine accessibility

Ensuring a more equitable distribution of vaccines worldwide is an effective strategy to control global pandemics and support economic recovery. We analyze the socioeconomic effects - defined as health gains, lockdown-easing effect, and supply-chain rebuilding benefit - of a set of idealized COVID-19 vaccine distribution scenarios. We find that an equitable vaccine distribution across the world would increase global economic benefits by 11.7% ($950 billion per year), compared to a scenario focusing on vaccinating the entire population within vaccine-producing countries, prioritizing in distributing vaccines to non-vaccine-producing countries. With incentives among lower-income countries, prioritizing the elderly who are at high risk of dying, together with the key front-line workforce who are at high risk of exposure is projected to be economically beneficial (e.g., 0.9%-3.4% annual GDP in India). Our results reveal how equitable distributions would cascade onto protection of vaccines to people and ways to improve vaccine equity and accessibility globally through international collaboration.